Tenpoint Therapeutics submitted an MAA for presbyopia to UK MHRA
The treatment addresses presbyopia, an age-related vision condition.
Latest Tenpoint Therapeutics News & Updates
See the latest news and media coverage for Tenpoint Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.
Ophthalmic therapeutics developer for age-related eye conditions
tenpointtherapeutics.com- Headquarters
- Irvine, United States
- Founded year
- 2019
- Company type
- Private company
- Number of employees
- 125–200
- Industry
- Pharmaceuticals
Last updated
Latest news about Tenpoint Therapeutics
In short: Tenpoint Therapeutics launched its presbyopia eye drop YUVEZZI in the U.S. after FDA approval and a merger with Visus Therapeutics.
Company announcements
Tenpoint Therapeutics welcomes Dr. Stephen Lane as Chief Medical Officer
Dr. Lane brings extensive ophthalmology experience. He oversees clinical development, medical affairs, and pharmacovigilance.
Tenpoint Therapeutics announces YUVEZZI™ availability in U.S.
YUVEZZI™ is carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%.
Tenpoint Therapeutics announces YUVEZZI™ availability in U.S.
YUVEZZI™ is carbachol and brimonidine tartrate ophthalmic solution 2.75%/0.1%.
Media coverage
Lupin inks pact with Tenpoint Therapeutics to commercialize YUVEZZI in select countries
Lupin said that its wholly owned subsidiary VISUfarma B.V. has entered into an exclusive licensing agreement with USA-based Visus Therapeutics Inc. for commercializing 'YUVEZZI' in...
Tenpoint Therapeutics Announces United Kingdom Submission of Marketing Authorization Application to the Medicines and Healthcare Products Regulatory Agency (MHRA) for the ...
Tenpoint Therapeutics announced the submission of an MAA to the United Kingdom's MHRA for the review of YUVEZZI™ for the treatment of presbyopia.
Ritedose Announces Manufacturing for Tenpoint Therapeutics' Presbyopia Eye Drop
The Ritedose Corporation, Inc. (Ritedose), the largest contract development manufacturing organization (CDMO) in the United States specializing in sterile Blow-Fill-Seal (BFS) production of unit dose...
Tenpoint Therapeutics, Ltd. Appoints Stephen S. Lane, M.D., as Chief Medical Officer
Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced the appointment...
Never miss news about Tenpoint Therapeutics
Track Tenpoint Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Tenpoint Therapeutics competitors & trending companies
Browse news for competitors to Tenpoint Therapeutics and other trending companies.
LENZ Therapeutics
Prolific
Oculis
Ticketplus
HELP Therapeutics
CMC
ManpowerGroup
Arcosa
Alliance Entertainment
QXO
Reliant Stones
Amber
The Pool Tile Co
Cinajus
Armstone
Eco Outdoor
Sareen Stone
Stone Planet
Salience Labs
Trio Petroleum
Arianespace
American Eagle
AEO
OLB
Compass
MAQS
Roschier
Möller & Partners
Normain
Incentive Industrier
Pinecone
SSHL
Videobuddy
Founders Alliance